Statement of Cash FlowsIndirect Method

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows:

		Dec. 31, 20Y3		Dec. 31, 20Y2
Assets
Cash		$300,500		$278,250
Accounts receivable (net)		108,860		99,930
Inventories		307,310		295,880
Investments		0		114,630
Land		157,620		0
Equipment		339,050		261,590
Accumulated depreciationequipment		(79,380)		(70,540)
	Total assets	$1,133,960		$979,740
Liabilities and Stockholders' Equity
Accounts payable (merchandise creditors)		$205,250		$193,010
Accrued expenses payable (operating expenses)		20,410		25,470
Dividends payable		11,340		8,820
Common stock, $10 par		61,230		48,010
Paid-in capital: Excess of issue price over par-common stock		230,190		133,240
Retained earnings		605,540		571,190
	Total liabilities and stockholders equity	$1,133,960		$979,740

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

The investments were sold for $134,120 cash.

Equipment and land were acquired for cash.

There were no disposals of equipment during the year.

The common stock was issued for cash.

There was a $80,400 credit to Retained Earnings for net income.

There was a $46,050 debit to Retained Earnings for cash dividends declared.

Required:

Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.

Livers Inc.
Statement of Cash Flows
For the Year Ended December 31, 20Y3
Cash flows from operating activities:
	$
Adjustments to reconcile net income to net cash flow from operating activities:
Changes in current operating assets and liabilities:
Net cash flow from operating activities		$
Cash flows from investing activities:
	$
Net cash flow used for investing activities
Cash flows from financing activities:
	$
Net cash flow from financing activities
		$
Cash at the beginning of the year
Cash at the end of the year		$